To analyze the results from 150 irradiations of an IMRT H&N phantom.
Methods and Materials:
A mailable anthropomorphic IMRT head and neck phantom was irradiated 150 times by 117 institutions. Some institutions irradiated multiple times. Institutions imaged the phantom, planned an IMRT treatment, performed their routine IMRT QA checks, and irradiated the phantom according to their plan. The phantom contained imageable structures representing a planning target volume (PTV) close to an organ at risk (OAR), simulating an oropharyngeal tumor and the spinal cord. The phantom also contained a secondary PTV that simulated peripheral nodes. TLDs were placed in each structure and a set of orthogonal radiochromic films intersected in the primary PTV. The following criteria were used to evaluate the measurements: TLD/institution dose -± 7%; distance-to-agreement in the high dose gradient region near the OAR -≤ 4 mm. The failure rate of institutions that housed 3 or fewer megavoltage therapy machines was compared to that of larger institutions. The results for all institutions was also analyzed by looking at the failure rates for types of accelerator, treatment planning systems, IMRT technique and the number of physicists per machine at the institution.
Conclusions:
Institutions of all sizes are capable of making mistakes in IMRT treatments. Sufficient physics coverage is an important aspect of IMRT quality assurance.
Failures occurred in irradiations delivered by a variety of models of linear accelerator and planned with several treatment planning systems (TPS). Somewhat consistent behavior was seen among the TPSs, although no trends were apparent among the delivery technique. The phantom was valuable for evaluating IMRT treatments at institutions preparing to participate in advanced technology clinical trials.
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Results:
43 irradiations failed to meet one or more of the criteria. 26 of the failures were dose discrepancies measured with TLD, 5 were dose distribution discrepancies measured with radiochromic film and 12 were disagreements in both TLD and film measurements. There was a 33% discrepancy rate in first-time irradiations at the institutions with 3 or fewer machines and a 29% rate at the larger institutions. All of the institutions that failed multiple times were smaller institutions. 83 institutions with 3 or fewer machines irradiated the phantom. 27 of the first time irradiations were failures. There were 6 repeat failures. 34 institutions with more than 3 machines irradiated the phantom. 10 of the first time irradiations were failures. There were no subsequent failures in this group.
The head and neck phantom consists of the following:
Primary PTV containing 4 TLD Secondary PTV containing 2 TLD Organ at risk containing 2 TLD GafChromic® film in axial and sagittal planes
The institution is instructed to give 6.6 Gy to at least 95% of the primary PTV. 5.4 Gy should be given to at least 95% of the secondary PTV. The organ at risk is limited to less than 4.5 Gy. 
Explanations for Failures
The following are known explanations for some of the failures:
• incorrect output factors in TPS
• incorrect PDD in TPS
• inadequacies in beam modeling at leaf ends (Cadman, et al; PMB 2002) • not adjusting MU to account for dose differences measured with ion chamber
• errors in couch indexing with Peacock system
• setup errors
The following graph shows the passing and failing irradiations sorted by the number of megavoltage therapy machines at the institution.
The following graph shows the passing and failing irradiations separated by the number of physicists per machine. There was a 32% failure rate for institutions employing less than 1 physicist per machine and a 27% failure rate for institutions employing 1 or more physicists per machine.
Results continued: Results continued: Methods and Materials continued:
The following tables detail results sorted by linear accelerator manufacturer, treatment planning system and IMRT technique. 
Distance to Agreement

Num ber of Results
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The following graphs show the spread of the results from the TLD in the PTVs and the spread of the DTA results.
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